Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Formulation of human antibodies for treating TNF-alpha associated disorders
No-Receipt date
2017-02099 - 20/06/2017
No-Filing date
20170401661 - 20/06/2017
No-Granting date
3092770 - 28/08/2017
No-EPO application date
10182610.5 - 15/08/2003
No-EPO granting date
2359856 - 10/05/2017
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
8/2017 - 23/10/2017
Expiration date
16/08/2023
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US22214016/08/2002/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 39/395
A61K 47/26
A61K 9/19
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
785971
ABBVIE BIOTECHNOLOGY LTD.
CLARENDON HOUSE 2, CHURCH STREET
HM 11 HAMILTON
BERMUDA
Inventors
Code
Firstname
Surname
1937402
KRAUSE, HANS-JUERGEN
1937403
BAUST, LISA
1937404
DICKES, MICHAEL
Representatives
Code
Firstname
Surname
Address
Town
Zip
3178
STEFANOS ALEXIOS
TSIMIKALIS "TSIMIKALIS KALONAROU DIKIGORIKI ETAIREIA"
NEOFYTOU VAMVA 1
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8126
STEFANOS ALEXIOS
TSIMIKALIS
NEOFYTOU VAMVA 1
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
3/7/2019 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 02/2019 Αρ. Πρωτ. ΓΔ 571 - 07/03/2019
Payments history
15 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).